Avantis Emerging Markets ex-China Equity ETF (AVXC)

On our desk, we are monitoring AVXC closely as institutional filings for Q2 2026 show 73 funds holding around $355 million. The narrative here is clear: investors are actively seeking emerging market exposure while mitigating mainland China concentration risks. With short interest plunging 85.4% in August down to just 11,402 shares, the bearish pressure has effectively dried up, leaving a very clean technical runway.

In evaluating quantitative allocations for our emerging market mandates, the decision to exclude China drastically alters the risk-reward matrix. AVXC trades at a modest forward P/E of roughly 14.8 to 15.5, backed by an SEC yield of 1.52% and quarterly payouts. However, quantitative analysts must factor in the modest daily trading volumes relative to its $449M asset base when executing large block trades.

From a risk management standpoint, AVXC presents an intriguing profile with a low beta hovering between 0.63 and 0.91 depending on the trailing window, and a Sharpe ratio reported around 1.68. The fund's rules-based active strategy charges a lean 0.33% net expense ratio, matching standard passive pricing while offering systematic factor tilts across 2,824 holdings.

Watching the macro backdrop, the structural shift away from mainland supply chains is acting as a major tailwind for ex-China strategies. AVXC has delivered a stellar start in 2026, capturing strong momentum in global tech and semiconductor demand across other emerging regions without getting bogged down by domestic regulatory overhangs in China.

Our options desk notes that despite the fund's healthy asset growth to over $415M, the lack of deep options liquidity limits complex hedging strategies. We are relying primarily on underlying equity adjustments or broad emerging market index puts rather than direct AVXC derivatives to manage downside risk.